Prelude Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,044
Closed -$234K 1331
2024
Q1
$234K Buy
+22,044
New +$234K 0.01% 921